A cost-utility analysis of etanercept for the treatment of moderate-to-severe psoriasis in Italy

Ketty Peris, Gl Colombo, S Di Matteo, Mc Fargnoli, M Esposito, A Mazzotta, S. Chimenti

Risultato della ricerca: Contributo in rivistaArticolo in rivista

14 Citazioni (Scopus)

Abstract

Biologic therapies have proven efficacious for patients with moderate-to-severe psoriasis. However, their economic value compared with standard of care in Italy has not been explored. This study estimates the cost-effectiveness of intermittent therapy with etanercept in patients with moderate-to-severe plaque-type psoriasis in comparison with nonsystemic therapy in Italy.
Lingua originaleEnglish
pagine (da-a)53-59
Numero di pagine7
RivistaClinicoEconomics and Outcomes Research
Volume1
Stato di pubblicazionePubblicato - 2009

Keywords

  • Markov model
  • cost-effectiveness
  • cost-utility
  • etanercept
  • psoriasis

Fingerprint Entra nei temi di ricerca di 'A cost-utility analysis of etanercept for the treatment of moderate-to-severe psoriasis in Italy'. Insieme formano una fingerprint unica.

Cita questo